Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZF2001 Booster Immunization Study
NCT05198063Phase 2Completed
- Sponsor
- Zhifei Biological
- Start
- Jan 2022
- Primary completion
- Aug 2022
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ZF2001 in coronavirus disease 2019 (COVID-19), sponsored by Zhifei Biological. Started Jan 2022; status: completed.
02
Drugs
ZF2001
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05198063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05198063.